HIV―プロテアーゼ阻害剤製造の中間体及びHIV―プロテアーゼ阻害剤の製造方法

Title:

HIV―プロテアーゼ阻害剤製造の中間体及びHIV―プロテアーゼ阻害剤の製造方法

Document Type and Number:

Japanese Patent JP4149000

Kind Code:

B2

Abstract:

The present invention is directed to a method of making the HIV-protease inhibitor nelfinavir mesylate.

More Like This:

JP2020037545	OXYGEN ISOTOPE-LABELED CARBOXYLATE COMPOUND, AGENT FOR OXYGEN ISOTOPE LABELING, MANUFACTURING METHOD OF OXYGEN ISOTOPE-LABELED CARBOXYLATE COMPOUND, AND MANUFACTURING METHOD OF OXYGEN ISOTOPE-LABELED ALCOHOL
WO/2013/129121	COMPOUND, LIQUID CRYSTAL COMPOSITION, POLYMER MATERIAL, AND FILM
JP2022504707	Aromatic compounds and their pharmaceutical uses

Inventors:

Whisten, Kathleen Earl
Dison, Michael

Application Number:

JP51283198A

Publication Date:

September 10, 2008

Filing Date:

September 04, 1997

Export Citation:

Assignee:

Agron Pharmaceuticals Incorporated
Japan Tobacco Inc.

International Classes:

C07C65/21; C07C67/08; C07C69/157; C07C69/86; C07D217/00; C07D217/26

Domestic Patent References:

JP8311024A

Attorney, Agent or Firm:

Kazuo Shamoto
Shosuke Imai
Tadashi Masui
Tadahiko Kurita
Yasushi Kobayashi
Hiroko Ejiri

Previous Patent: 高解像度コンピュータ型モニタでの実質的に運動の不連続性を伴なわない�...

Next Patent: METHOD FOR PACKING HYDROGEN STORAGE ALLOY INTO REACTION VESSEL